tiprankstipranks
Analyst Profile
Followed by 4 other investors
.
Rosie Turner

Rosie Turner

Jefferies
Wall Street Analyst
Ranked #6,002 out of 8,047 Analysts on TipRanks (#15,842 out of 21,521 overall experts)

Success Rate

33%
6 out of 18 Profitable Transactions

Average Return

-2.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Rosie Turner's ratings since 2021 and opened each position for the duration of 1 Year:
33.33% of your transactions would have been profitable with an average return of -2.9%

Stock Rating Distribution

35Ratings
48.57% Buy
42.86% Hold
8.57% Sell
Distribution of Rosie Turner's ratings

Additional Information

Main Sector:General
Geo Coverage:
United KingdomUK Market
United StatesUS Market

Best Rating

Stock:
Novo Nordisk A/S (UK)
(GB:0QIU)
Rating Type:Buy
Dates:May 05, 2021 - May 05, 2022
Gain:72.10%
The most profitable rating made by Rosie Turner

Rosie Turner's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Novo Nordisk
Buy
Reiterated
kr495.00
(-35.71% Downside)
100%
+72.10%
1
Galapagos
Hold
Downgraded
$51.32
(-5.41% Downside)
0%
-27.15%
3
Morphosys
Hold
Reiterated
€47.00
(107.46% Upside)
0.00%
3
Hikma Pharmaceuticals
Buy
Reiterated
3,000.00p
(95.31% Upside)
0%
-36.73%
3
arGEN X
Buy
Reiterated
€330.00
(-10.12% Downside)
100%
+46.20%
3
Swedish Orphan Biovitrum AB
Hold
Reiterated
kr190.00
(-18.92% Downside)
0.00%
4
Grifols
Sell
Reiterated
€16.00
(16.32% Upside)
40%
+0.16%
6
Grifols SA
Hold
Initiated
$18.06
(100.71% Upside)
0%
-31.50%
2
Galapagos
Sell
Downgraded
€48.00
(-9.65% Downside)
0%
-5.40%
2
UCB SA
Hold
Downgraded
€85.00
(15.46% Upside)
0.00%
1
List of latest recommendations made by Rosie Turner. Click to expand and see Rosie Turner's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More